Evidence map›Paper›PMID 34208090›Full record

ArticleCancers2021

Magnetically Guided Localization Using a Guiding-Marker System

Tomoko Kurita, Kanae Taruno, Seigo Nakamura, Hiroyuki Takei, Katsutoshi Enokido, Takashi Kuwayama, Yoko Kanada, Sadako Akashi-Tanaka, Misaki Matsuyanagi, Meishi Hankyo and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Tomoko KuritaDepartment of Breast Surgery and Oncology, Nippon Medical School Hospital, Tokyo 113-8603, Japan.ORCID 0000-0002-6139-5996
Kanae TarunoDivision of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Seigo NakamuraDivision of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Hiroyuki TakeiDepartment of Breast Surgery and Oncology, Nippon Medical School Hospital, Tokyo 113-8603, Japan.
Katsutoshi EnokidoDivision of Breast Surgical Oncology, Department of Surgery, Showa University Fujigaoka Hospital, Kanagawa 227-8501, Japan.
Takashi KuwayamaDivision of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Yoko KanadaDivision of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Sadako Akashi-TanakaDivision of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.ORCID 0000-0002-2065-7742
Misaki MatsuyanagiDivision of Breast Surgical Oncology, Department of Surgery, Showa University Fujigaoka Hospital, Kanagawa 227-8501, Japan.
Meishi HankyoDepartment of Breast Surgery and Oncology, Nippon Medical School Hospital, Tokyo 113-8603, Japan.
Keiko YanagiharaDepartment of Breast Surgery and Oncology, Nippon Medical School Hospital, Tokyo 113-8603, Japan.ORCID 0000-0003-2708-4550
Takashi SakataniDepartment of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo 113-8603, Japan.
Kentaro SakamakiCenter for Data Science, Yokohama City University, Yokohama 236-0027, Japan.
Akihiro KuwahataGraduate School of Engineering, University of Tokyo, Tokyo 113-8656, Japan.
Masaki SekinoGraduate School of Engineering, University of Tokyo, Tokyo 113-8656, Japan.
Moriaki KusakabeGraduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo 113-8657, Japan.
Nippon Medical School Hospital · JPShowa University · JPShowa University Fujigaoka Hospital · JP3-D Matrix (Japan) · JPThe University of Tokyo · JPTohoku University · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate pre-operative localization of nonpalpable lesions plays a pivotal role in guiding breast-conserving surgery (BCS). In this multicenter feasibility study, nonpalpable breast lesions were localized using a handheld magnetic probe (TAKUMI) and a magnetic marker (Guiding-Marker System

Indexed as

breast cancermagnetic makermagnetic probenonpalpable breast lesionsurgery

Identifiers

PMID34208090
PMCPMC8230842
OpenAlexW3168575044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.